1135299-95-4Relevant academic research and scientific papers
Replacing alkyl sulfonamide with aromatic sulfonamide in sulfonamide-type RXR agonists favors switch towards antagonist activity
Morishita, Ken-ichi,Yakushiji, Nobumasa,Ohsawa, Fuminori,Takamatsu, Kayo,Matsuura, Nobuyasu,Makishima, Makoto,Kawahata, Masatoshi,Yamaguchi, Kentaro,Tai, Akihiro,Sasaki, Kenji,Kakuta, Hiroki
supporting information; experimental part, p. 1001 - 1003 (2009/09/25)
Retinoid X receptor (RXR) ligands are attractive candidates for clinical application because of their activity against tamoxifen-resistant breast cancer, taxol-resistant lung cancer, metabolic syndrome, and allergy. Though several RXR ligands, especially
